CN101385875A - 一种可完全降解吸收的药物缓释镁合金支架及应用 - Google Patents
一种可完全降解吸收的药物缓释镁合金支架及应用 Download PDFInfo
- Publication number
- CN101385875A CN101385875A CNA2007100128081A CN200710012808A CN101385875A CN 101385875 A CN101385875 A CN 101385875A CN A2007100128081 A CNA2007100128081 A CN A2007100128081A CN 200710012808 A CN200710012808 A CN 200710012808A CN 101385875 A CN101385875 A CN 101385875A
- Authority
- CN
- China
- Prior art keywords
- magnesium alloy
- support
- degradable
- medicine
- release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910000861 Mg alloy Inorganic materials 0.000 title claims abstract description 62
- 239000003814 drug Substances 0.000 title claims abstract description 49
- 230000002745 absorbent Effects 0.000 title 1
- 239000002250 absorbent Substances 0.000 title 1
- 239000010410 layer Substances 0.000 claims abstract description 23
- 239000011248 coating agent Substances 0.000 claims abstract description 14
- 238000000576 coating method Methods 0.000 claims abstract description 14
- 229940079593 drug Drugs 0.000 claims abstract description 14
- 208000037803 restenosis Diseases 0.000 claims abstract description 6
- 239000000758 substrate Substances 0.000 claims abstract description 3
- 229910045601 alloy Inorganic materials 0.000 claims description 17
- 239000000956 alloy Substances 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 14
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 14
- 239000007943 implant Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 229920002521 macromolecule Polymers 0.000 claims description 9
- 229910052749 magnesium Inorganic materials 0.000 claims description 9
- 239000011777 magnesium Substances 0.000 claims description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 8
- 229910052697 platinum Inorganic materials 0.000 claims description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- 239000001488 sodium phosphate Substances 0.000 claims description 6
- 230000001028 anti-proliverative effect Effects 0.000 claims description 5
- 230000007797 corrosion Effects 0.000 claims description 5
- 238000005260 corrosion Methods 0.000 claims description 5
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 5
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 5
- 235000019800 disodium phosphate Nutrition 0.000 claims description 5
- 229910052715 tantalum Inorganic materials 0.000 claims description 5
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 claims description 5
- 208000007536 Thrombosis Diseases 0.000 claims description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 4
- 238000005229 chemical vapour deposition Methods 0.000 claims description 4
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 4
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 4
- 239000002861 polymer material Substances 0.000 claims description 4
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 4
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 4
- 235000011008 sodium phosphates Nutrition 0.000 claims description 4
- 238000005507 spraying Methods 0.000 claims description 4
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 4
- 239000011575 calcium Substances 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- 239000010409 thin film Substances 0.000 claims description 3
- 229910001051 Magnalium Inorganic materials 0.000 claims description 2
- PGTXKIZLOWULDJ-UHFFFAOYSA-N [Mg].[Zn] Chemical class [Mg].[Zn] PGTXKIZLOWULDJ-UHFFFAOYSA-N 0.000 claims description 2
- 229910052782 aluminium Inorganic materials 0.000 claims description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 2
- 210000001367 artery Anatomy 0.000 claims description 2
- 210000003445 biliary tract Anatomy 0.000 claims description 2
- ZFXVRMSLJDYJCH-UHFFFAOYSA-N calcium magnesium Chemical class [Mg].[Ca] ZFXVRMSLJDYJCH-UHFFFAOYSA-N 0.000 claims description 2
- 238000007654 immersion Methods 0.000 claims description 2
- 238000005468 ion implantation Methods 0.000 claims description 2
- 238000007733 ion plating Methods 0.000 claims description 2
- KBMLJKBBKGNETC-UHFFFAOYSA-N magnesium manganese Chemical class [Mg].[Mn] KBMLJKBBKGNETC-UHFFFAOYSA-N 0.000 claims description 2
- -1 magnesium rare earth metal Chemical class 0.000 claims description 2
- QRNPTSGPQSOPQK-UHFFFAOYSA-N magnesium zirconium Chemical class [Mg].[Zr] QRNPTSGPQSOPQK-UHFFFAOYSA-N 0.000 claims description 2
- 229910052748 manganese Inorganic materials 0.000 claims description 2
- 239000011572 manganese Substances 0.000 claims description 2
- 210000005259 peripheral blood Anatomy 0.000 claims description 2
- 239000011886 peripheral blood Substances 0.000 claims description 2
- 229910052761 rare earth metal Inorganic materials 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 210000003437 trachea Anatomy 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- 239000011701 zinc Substances 0.000 claims description 2
- 229910052726 zirconium Inorganic materials 0.000 claims description 2
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 229940041181 antineoplastic drug Drugs 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 239000002345 surface coating layer Substances 0.000 claims 1
- 210000000748 cardiovascular system Anatomy 0.000 abstract description 5
- 230000000007 visual effect Effects 0.000 abstract description 2
- 229920006237 degradable polymer Polymers 0.000 abstract 1
- 239000011241 protective layer Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 description 15
- 239000002344 surface layer Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 12
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 9
- 239000007921 spray Substances 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 238000006731 degradation reaction Methods 0.000 description 8
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 230000015556 catabolic process Effects 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 230000000259 anti-tumor effect Effects 0.000 description 5
- 238000003618 dip coating Methods 0.000 description 5
- 238000005498 polishing Methods 0.000 description 5
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 5
- 229960002930 sirolimus Drugs 0.000 description 5
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 5
- 238000001291 vacuum drying Methods 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 229920000954 Polyglycolide Polymers 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000002513 implantation Methods 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 229920000747 poly(lactic acid) Polymers 0.000 description 4
- 239000004633 polyglycolic acid Substances 0.000 description 4
- 239000004626 polylactic acid Substances 0.000 description 4
- 238000004381 surface treatment Methods 0.000 description 4
- 238000004506 ultrasonic cleaning Methods 0.000 description 4
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 3
- 229930012538 Paclitaxel Natural products 0.000 description 3
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 3
- 239000000084 colloidal system Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229960002897 heparin Drugs 0.000 description 3
- 229920000669 heparin Polymers 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 229960001592 paclitaxel Drugs 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 3
- 101001108245 Cavia porcellus Neuronal pentraxin-2 Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229910001425 magnesium ion Inorganic materials 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229920001610 polycaprolactone Polymers 0.000 description 2
- 239000004632 polycaprolactone Substances 0.000 description 2
- 239000012890 simulated body fluid Substances 0.000 description 2
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920002730 Poly(butyl cyanoacrylate) Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229910004337 Ti-Ni Inorganic materials 0.000 description 1
- 229910011209 Ti—Ni Inorganic materials 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 238000005275 alloying Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000009713 electroplating Methods 0.000 description 1
- 239000007792 gaseous phase Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- KHYBPSFKEHXSLX-UHFFFAOYSA-N iminotitanium Chemical compound [Ti]=N KHYBPSFKEHXSLX-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- SJCKRGFTWFGHGZ-UHFFFAOYSA-N magnesium silver Chemical class [Mg].[Ag] SJCKRGFTWFGHGZ-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000007751 thermal spraying Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000009785 tube rolling Methods 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100128081A CN101385875B (zh) | 2007-09-12 | 2007-09-12 | 一种可完全降解吸收的药物缓释镁合金支架及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100128081A CN101385875B (zh) | 2007-09-12 | 2007-09-12 | 一种可完全降解吸收的药物缓释镁合金支架及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101385875A true CN101385875A (zh) | 2009-03-18 |
CN101385875B CN101385875B (zh) | 2012-07-25 |
Family
ID=40475675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007100128081A Active CN101385875B (zh) | 2007-09-12 | 2007-09-12 | 一种可完全降解吸收的药物缓释镁合金支架及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101385875B (zh) |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102309369A (zh) * | 2010-07-09 | 2012-01-11 | 微创医疗器械(上海)有限公司 | 一种金属支架及其制备方法 |
CN102309368A (zh) * | 2010-07-09 | 2012-01-11 | 微创医疗器械(上海)有限公司 | 一种人体管腔载药支架及其制备方法 |
WO2012003803A1 (zh) * | 2010-07-09 | 2012-01-12 | 微创医疗器械(上海)有限公司 | 一种载药金属支架及其制备方法 |
CN101632842B (zh) * | 2009-08-20 | 2012-08-22 | 华南理工大学 | 一种用于镁合金血管内支架表面的改性方法 |
CN102727944A (zh) * | 2011-11-14 | 2012-10-17 | 上海市第一人民医院 | 抗胆管良、恶性狭窄的药物涂层支架及制备方法 |
CN102727948A (zh) * | 2011-11-14 | 2012-10-17 | 上海市第一人民医院 | 生物可降解镁合金胆管溶石镂刻支架及制备方法 |
CN102908216A (zh) * | 2012-10-30 | 2013-02-06 | 东南大学 | 生物可吸收医用人体腔道内支架及其制备方法 |
CN103110985A (zh) * | 2012-12-26 | 2013-05-22 | 深圳市昕力医疗设备开发有限公司 | 一种有多种药物的生物可降解支架 |
CN103566415A (zh) * | 2012-08-02 | 2014-02-12 | 上海微创医疗器械(集团)有限公司 | 一种双面涂层的人体血管植入物及其制作方法 |
CN103705294A (zh) * | 2012-09-28 | 2014-04-09 | 上海微创骨科医疗科技有限公司 | 多功能复合药物涂层缓释系统及其制备方法 |
CN103948453A (zh) * | 2014-04-21 | 2014-07-30 | 上海市第六人民医院 | 一种可降解镁合金覆膜支架及覆膜支架系统 |
US8888841B2 (en) | 2010-06-21 | 2014-11-18 | Zorion Medical, Inc. | Bioabsorbable implants |
CN104784750A (zh) * | 2015-04-03 | 2015-07-22 | 中国科学院金属研究所 | 提高变形性生物镁合金植入器件耐蚀性的表面改性方法 |
CN105457105A (zh) * | 2015-07-24 | 2016-04-06 | 中国科学院金属研究所 | 一种新型可显影镁合金血管支架 |
CN106399771A (zh) * | 2016-09-30 | 2017-02-15 | 东北大学 | 一种钢液镁处理用缓释镁合金的制备方法 |
CN106620837A (zh) * | 2017-01-18 | 2017-05-10 | 杨水祥 | 一种制备镁合金血管支架的制备方法 |
CN106726035A (zh) * | 2016-12-30 | 2017-05-31 | 张方亮 | 可降解镁合金食管支架及其制备方法 |
CN106821562A (zh) * | 2016-12-30 | 2017-06-13 | 张方亮 | 可降解镁合金胰管支架及其制备方法 |
CN108378929A (zh) * | 2018-04-11 | 2018-08-10 | 西安卓恰医疗器械有限公司 | 以可降解金属制成的定位标记物及其制备方法 |
CN108785755A (zh) * | 2018-06-28 | 2018-11-13 | 王缨 | 镁合金在制备可降解胆道支架中的应用 |
CN109893682A (zh) * | 2019-04-16 | 2019-06-18 | 东北大学 | 一种具有复合结构的可降解金属输尿管支架及制备方法 |
CN112120696A (zh) * | 2020-09-29 | 2020-12-25 | 中国科学院上海微系统与信息技术研究所 | 一种结合药物递送的深部柔性脑电极的植入方法 |
CN112472879A (zh) * | 2020-12-21 | 2021-03-12 | 上海康德莱医疗器械股份有限公司 | 一种镁合金支架及其制备方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012075311A2 (en) | 2010-12-01 | 2012-06-07 | Zorion Medical, Inc. | Magnesium-based absorbable implants |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10322182A1 (de) * | 2003-05-16 | 2004-12-02 | Blue Membranes Gmbh | Verfahren zur Herstellung von porösem, kohlenstoffbasiertem Material |
CN1321705C (zh) * | 2004-07-02 | 2007-06-20 | 清华大学 | x射线下可视的多层药物复合可降解胆道支架的制备方法 |
CN100400114C (zh) * | 2005-04-30 | 2008-07-09 | 中国科学院金属研究所 | 可控降解速率的生物医用植入材料及其应用 |
CN2936196Y (zh) * | 2006-06-02 | 2007-08-22 | 中国科学院金属研究所 | 可吸收金属镁植入支架 |
CN100488575C (zh) * | 2006-12-27 | 2009-05-20 | 天津大学 | 具有双重可控释放涂层的可吸收镁合金支架及其制备方法 |
-
2007
- 2007-09-12 CN CN2007100128081A patent/CN101385875B/zh active Active
Cited By (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101632842B (zh) * | 2009-08-20 | 2012-08-22 | 华南理工大学 | 一种用于镁合金血管内支架表面的改性方法 |
US9849008B2 (en) | 2010-06-21 | 2017-12-26 | Zorion Medical, Inc. | Bioabsorbable implants |
US8888841B2 (en) | 2010-06-21 | 2014-11-18 | Zorion Medical, Inc. | Bioabsorbable implants |
CN102309368A (zh) * | 2010-07-09 | 2012-01-11 | 微创医疗器械(上海)有限公司 | 一种人体管腔载药支架及其制备方法 |
WO2012003803A1 (zh) * | 2010-07-09 | 2012-01-12 | 微创医疗器械(上海)有限公司 | 一种载药金属支架及其制备方法 |
CN102309368B (zh) * | 2010-07-09 | 2014-11-05 | 上海微创医疗器械(集团)有限公司 | 一种人体管腔载药支架及其制备方法 |
CN102309369B (zh) * | 2010-07-09 | 2014-11-05 | 上海微创医疗器械(集团)有限公司 | 一种金属支架及其制备方法 |
CN102309369A (zh) * | 2010-07-09 | 2012-01-11 | 微创医疗器械(上海)有限公司 | 一种金属支架及其制备方法 |
CN102727944A (zh) * | 2011-11-14 | 2012-10-17 | 上海市第一人民医院 | 抗胆管良、恶性狭窄的药物涂层支架及制备方法 |
CN102727948A (zh) * | 2011-11-14 | 2012-10-17 | 上海市第一人民医院 | 生物可降解镁合金胆管溶石镂刻支架及制备方法 |
CN103566415A (zh) * | 2012-08-02 | 2014-02-12 | 上海微创医疗器械(集团)有限公司 | 一种双面涂层的人体血管植入物及其制作方法 |
CN103566415B (zh) * | 2012-08-02 | 2016-08-03 | 上海微创医疗器械(集团)有限公司 | 一种双面涂层的人体血管植入物及其制作方法 |
CN103705294A (zh) * | 2012-09-28 | 2014-04-09 | 上海微创骨科医疗科技有限公司 | 多功能复合药物涂层缓释系统及其制备方法 |
CN103705294B (zh) * | 2012-09-28 | 2016-03-02 | 上海微创骨科医疗科技有限公司 | 多功能复合药物涂层缓释系统及其制备方法 |
WO2014067202A1 (zh) * | 2012-10-30 | 2014-05-08 | 东南大学 | 生物可吸收医用人体腔道内支架及其制备方法 |
CN102908216A (zh) * | 2012-10-30 | 2013-02-06 | 东南大学 | 生物可吸收医用人体腔道内支架及其制备方法 |
CN103110985A (zh) * | 2012-12-26 | 2013-05-22 | 深圳市昕力医疗设备开发有限公司 | 一种有多种药物的生物可降解支架 |
CN103948453A (zh) * | 2014-04-21 | 2014-07-30 | 上海市第六人民医院 | 一种可降解镁合金覆膜支架及覆膜支架系统 |
CN104784750A (zh) * | 2015-04-03 | 2015-07-22 | 中国科学院金属研究所 | 提高变形性生物镁合金植入器件耐蚀性的表面改性方法 |
CN105457105A (zh) * | 2015-07-24 | 2016-04-06 | 中国科学院金属研究所 | 一种新型可显影镁合金血管支架 |
CN106399771A (zh) * | 2016-09-30 | 2017-02-15 | 东北大学 | 一种钢液镁处理用缓释镁合金的制备方法 |
CN106399771B (zh) * | 2016-09-30 | 2017-12-01 | 东北大学 | 一种钢液镁处理用缓释镁合金的制备方法 |
CN106726035A (zh) * | 2016-12-30 | 2017-05-31 | 张方亮 | 可降解镁合金食管支架及其制备方法 |
CN106821562A (zh) * | 2016-12-30 | 2017-06-13 | 张方亮 | 可降解镁合金胰管支架及其制备方法 |
CN106620837A (zh) * | 2017-01-18 | 2017-05-10 | 杨水祥 | 一种制备镁合金血管支架的制备方法 |
CN106620837B (zh) * | 2017-01-18 | 2020-01-24 | 杨水祥 | 一种制备镁合金血管支架的制备方法 |
CN108378929A (zh) * | 2018-04-11 | 2018-08-10 | 西安卓恰医疗器械有限公司 | 以可降解金属制成的定位标记物及其制备方法 |
CN108785755A (zh) * | 2018-06-28 | 2018-11-13 | 王缨 | 镁合金在制备可降解胆道支架中的应用 |
CN109893682A (zh) * | 2019-04-16 | 2019-06-18 | 东北大学 | 一种具有复合结构的可降解金属输尿管支架及制备方法 |
CN112120696A (zh) * | 2020-09-29 | 2020-12-25 | 中国科学院上海微系统与信息技术研究所 | 一种结合药物递送的深部柔性脑电极的植入方法 |
CN112472879A (zh) * | 2020-12-21 | 2021-03-12 | 上海康德莱医疗器械股份有限公司 | 一种镁合金支架及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101385875B (zh) | 2012-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101385875B (zh) | 一种可完全降解吸收的药物缓释镁合金支架及应用 | |
US11590266B2 (en) | Biodegradable iron-containing compositions, methods of preparing and applications therefor | |
CN107460371B (zh) | 一种Zn-Li系锌合金及其制备方法与应用 | |
CN100400114C (zh) | 可控降解速率的生物医用植入材料及其应用 | |
CN107460372B (zh) | 一种Zn-Mn系锌合金及其制备方法与应用 | |
CN104857570B (zh) | 一种可降解锌基合金支架及其制备方法 | |
TWI517865B (zh) | 以超純鎂為基底材質形成之生物可降解之植入性醫療器材 | |
CN101468216A (zh) | 一种带药可降解镁合金心血管支架及其制备方法 | |
CN104212998A (zh) | 一种Zn-Mg系锌合金及其制备方法与应用 | |
US11896735B2 (en) | Ultrahigh ductility, novel Mg—Li based alloys for biomedical applications | |
CN102908216A (zh) | 生物可吸收医用人体腔道内支架及其制备方法 | |
CN107519539A (zh) | 一种医用可降解锌基合金材料及其血管支架制品 | |
EP2135628A2 (de) | Stent mit einer Beschichtung oder einem Grundkörper, der ein Lithiumsalz enthält, und Verwendung von Lithiumsalzen zur Restenoseprophylaxe | |
CN104888282B (zh) | 一种可降解锌基微孔载药支架及其制备方法 | |
CN108277386A (zh) | 一种Zn-Li-Mg系锌合金及其制备方法与应用 | |
CN106310372B (zh) | 可降解镁基骨内植物可载药高分子/钙磷复合涂层及制备 | |
CN102151185A (zh) | 一种具有多层涂层的生物可降解支架 | |
CN104195369A (zh) | 一种Zn-Ca系锌合金及其制备方法与应用 | |
CN107281543A (zh) | 一种表面多重防护的生物医用镁或镁合金植入材料 | |
CN2936196Y (zh) | 可吸收金属镁植入支架 | |
CN108315583A (zh) | 一种Zn-Li-Mn系锌合金及其制备方法与应用 | |
CN105568103A (zh) | 一种可降解生物医用镁合金 | |
CN114767950B (zh) | 一种镁合金支架用的防腐与载药复合涂层及其制备方法 | |
CN108815589A (zh) | 一种医用可降解锌基合金血管支架制品 | |
Niu et al. | Research and development strategy for biodegradable magnesium-based vascular stents: a review |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING JINXIN KECHUANG BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: METALLIC INSTITUTE, CHINESE ACADEMY OF SCIENCES Effective date: 20140721 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 110016 SHENYANG, LIAONING PROVINCE TO: 101101 TONGZHOU, BEIJING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140721 Address after: 101101 Beijing city Tongzhou District Beiyuan Hospital No. 155 West Building Room 333 Patentee after: Beijing Jinxin Kechuang biotechnology limited liability company Address before: 110016 Shenyang, Liaoning Province Cultural Road, No. 72, Shenhe Patentee before: Institute of metal research, Chinese Academy of Sciences |